Our findings not only reveal the pivotal roles of circMRPS35 in governing histone modification in anticancer treatment, but also advocate for triggering circMRPS35/KAT7/FOXO1/3a pathway to combat gastric cancer.
CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification.